| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |